ROCKWELL MEDICAL, INC. (RMTI)
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Address
30142 WIXOM ROAD
WIXOM, MI 48393
Founded
1996
Number of Employees
237
Website
http://www.rockwellmed.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | $2,913 | - | $2,287 | - | - | - | - | - | - | - | $2,600 |
| Average Price | - | $110.44 | - | $79.20 | - | - | - | - | - | - | - | $94.11 |
| # Shares Purchased | - | 26,375 | - | 28,879 | - | - | - | - | - | - | - | 27,627 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | -97.3% | - | -96.2% | - | - | - | - | - | - | - | -96.8% |
| S&P 500 Return to Date | - | 173.0% | - | 129.7% | - | - | - | - | - | - | - | 151.3% |
| Excess Total Return | - | -270.2% | - | -225.9% | - | - | - | - | - | - | - | -248.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | 1% | - | 0% | - | - | - | - | - | - | - | 1% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at RMTI make a trade.
Creating a free account takes less than one minute